- Q1 2024 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$25.04 (-3.36%)Earnings
- Q4 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2024$28.89 (-2.43%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Mirum Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023$28.39 (-0.11%)Earnings
- Mirum Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Mirum Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023$24.88 (-0.16%)Earnings
- Mirum Pharmaceuticals Inc To Acquire Travere Therapeutics Inc Call TranscriptJul 17, 2023
- Q1 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$27.85 (-2.59%)Earnings
- Q4 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 08, 2023$23.76 (-0.13%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022$20.02 (-16.37%)Earnings
- Mirum Pharmaceuticals Inc To Discuss The Topline Data From the MARCH Study Call TranscriptOct 24, 2022
- Q2 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$26.05 (+11.80%)Earnings
- Q1 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$25.03 (+6.15%)Earnings
- Q4 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 09, 2022$22.8 (+7.55%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$15.49 (-2.46%)Earnings
- Mirum Pharmaceuticals Inc To Discuss FDA Approves LIVMARLI Call TranscriptSep 29, 2021
- Q2 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$14.54 (-0.62%)Earnings
- Q1 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021$17.7 (-6.50%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Mirum Pharmaceuticals Inc Corporate Analyst Meeting TranscriptDec 09, 2020
Mirum Pharmaceuticals Inc To Discuss The Topline Data From the MARCH Study Call Transcript
Hello, and a warm welcome to the Mirum Phase III Top Line Results Conference Call. My name is Candice, and I'll be your moderator for today's call. (Operator Instructions)
I would now like to pass you over to our host for today's call, Ian Clements, CFO. Please go ahead.
Thanks, Candice, and good morning, everyone. I'd like to welcome you to Mirum's MARCH-PFIC Phase III top line results conference call. I'm joined today by President and CEO, Chris Peetz; Head of R&D, Pam Vig, Chief Development Officer, Lara Longpre; and Chief Operating Officer, Peter Radovich. Earlier this morning, Mirum issued a news release announcing positive results from our Phase III MARCH study. Copies of the news release can be found in the IR section of our website. Also in the IR section of our website, you can find a slide deck outlining results in this study. We will refer to this deck as we go through the results this morning.
Before we begin, I'd like to remind you that during the course of this conference call,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)